VEGFA and breast carcinoma: We have obtained higher SP for VEGF-A and similar SP for CA 15–3 in our previous work in breast cancer [6], but in this work, we have used different method for calculating SP (95th percentile, not Youden index as now), which may be the reason for the differences in the ratio of diagnostic sensitivity and specificity.